Biotech Startups

Mable is a genomics-based telehealth platform that provides personalized migraine care by analyzing patients' genetic and biomarker data to inform individualized treatment plans. The company serves migraine sufferers seeking precision medicine alternatives to traditional trial-and-error medication approaches.

3 investors

Madrigal Pharmaceuticals is a biopharmaceutical company developing treatments for metabolic-associated steatohepatitis (MASH). The company focuses on improving care for patients with this liver disease through innovative drug development and collaboration.

3 investors

Magic Valley is an Australian cultivated meat company using iPSC technology to produce real meat without animal farming. The company targets consumers and the broader food industry seeking sustainable meat alternatives.

3 investors

Mariana Oncology, a Novartis company, develops precision radioligand therapies that deliver radioisotopes to diseased cells while limiting effects on healthy tissue. Its pipeline targets challenging cancers with the goal of improving both treatment efficacy and patient experience.

3 investors

Marinatex creates plastic-free coatings and films derived from seafood processing byproducts that are designed to biodegrade safely. The company's materials serve packaging and agriculture businesses seeking alternatives to conventional plastics without requiring manufacturing process changes.

3 investors

Massive Bio operates an AI-based platform that matches cancer patients with oncology clinical trials and provides concierge support throughout the trial process. It serves patients across the U.S., Canada, Latin America, and Europe, and works with pharma and CRO customers, patient advocacy organizations, and the National Cancer Institute's network of cancer centers.

3 investors

Discovering precision small molecule medicines that harness the power of covalency to transform the treatment of immune diseases.

3 investors

Maxwell Biomedical develops a device-based alternative to catheter ablation for atrial fibrillation, using closed-loop adaptive left atrial multisite pacing and Spatial Resynchronization Therapy (SRT) to terminate AF without high-energy shock. Its work centers on wirelessly powered leadless pacemakers and cardiac resynchronization technology for cardiac rhythm disorders.

3 investors

Developer of oral vaccines for livestock with cost-effective delivery.

3 investors

MediBeacon develops biocompatible fluorescent tracer agents detected by skin sensors for clinical diagnostic applications including kidney function assessment and gastrointestinal permeability measurement. The company's medical technology platform serves clinicians managing patients with kidney disease and inflammatory bowel disorders, with additional applications in surgical visualization and preclinical research.

3 investors

Medic Life Sciences applies CRISPR functional genomics in 3D patient tumor-like cancer models to identify biomarkers, synthetic lethality, and resistance mutations for oncology drug development. The company focuses on discovering genetic features of cancer with translational relevance for stratifying patients and finding novel drug targets.

3 investors

Medium Bio engineers customized proteins using AI and protein design to create affinity reagents for research teams and diagnostic developers. The company accelerates molecular tool development from design to experimental validation within weeks.

3 investors

Medytox is a South Korean biopharmaceutical company that develops and manufactures botulinum toxin products and hyaluronic acid dermal fillers. Founded in 2000, it operates domestic R&D centers and production plants in Korea along with subsidiaries and joint ventures in the US, Taiwan, Hong Kong, Thailand, and Japan.

3 investors

Meiogenix develops a proprietary recombination technology that targets meiotic recombination to accelerate genetic gain and variety development in crops. It serves plant breeders through crop innovation partnerships and large-scale technology licensing, working on both specialty crops (tomato, fruits, vegetables) and field crops (corn, rice, wheat, soybean).

3 investors

Privately-held biotech company developing biologic therapies for retinal diseases

3 investors

Mereo BioPharma is a biopharmaceutical company publicly traded on Nasdaq under the ticker MREO. This page presents its share price data and SEC filings for investors and commercial partners.

3 investors

Merida is a biotherapeutics company developing a new class of drugs designed to selectively and durably eliminate the pathogenic antibodies that drive autoimmune and allergic diseases. Its work spans discovery, drug development, and clinical operations aimed at treating patients with these conditions.

3 investors

Metagenomi is a genetic medicines company developing therapies based on gene editing technologies to treat patients with serious diseases. It operates in the biotech sector, working on translational and clinical development of genetic medicine programs.

3 investors

Metri is a biotech company developing first-in-class, disease-modifying therapeutics for endometriosis and other uterine diseases originating in the endometrium. It is building a platform to identify reliable disease targets for conditions that currently lack targeted treatments.

3 investors

MiCAN Technologies produces immortalized blood cells (erythroid and myeloid-lineage cells) using regenerative medicine technology, supplying research-use blood-like cells, evaluation kits, and contract testing services. Its products serve infectious disease research and the efficacy/safety evaluation of pharmaceuticals and functional materials, including a pyrogen (fever-inducing substance) alternative testing kit.

3 investors

Micropep develops natural crop protection solutions using micropeptides—short protein molecules that regulate plant genes and proteins—for farmers seeking sustainable alternatives. The French-founded agricultural biotech company operates globally with expansion into the USA.

3 investors

MicroMGx runs a high-throughput natural product discovery process that combines metabolomics and genomics (metabologenomics) to find bioactive compounds produced by microbes, supplying patented natural products to life science R&D organizations. Its portfolio includes a novel-mode-of-action herbicide and an anti-parasitic anthelmintic candidate for use in crops, livestock, pets, and humans.

3 investors

Micron Biomedical develops dissolvable microarray technology for vaccine and therapeutic delivery as an alternative to traditional injections, targeting expanded global access to treatments across all age groups. The company operates at the clinical stage and is building manufacturing capacity for needle-free pharmaceuticals.

3 investors

US-based AI-driven data intelligence platform for drug discovery and computational biology.

3 investors